Literature DB >> 7533301

Picornavirus inhibitors.

L Carrasco1.   

Abstract

Picornaviruses are among the best understood animal viruses in molecular terms. A number of important human and animal pathogens are members of the Picornaviridae family. The genome organization, the different steps of picornavirus growth and numerous compounds that have been reported as inhibitors of picornavirus functions are reviewed. The picornavirus particles and several agents that interact with them have been solved at atomic resolution, leading to computer-assisted drug design. Picornavirus inhibitors are useful in aiding a better understanding of picornavirus biology. In addition, some of them are promising therapeutic agents. Clinical efficacy of agents that bind to picornavirus particles has already been demonstrated.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7533301      PMCID: PMC7133639          DOI: 10.1016/0163-7258(94)90040-x

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  532 in total

1.  SUPPRESSION OF THE INHIBITORY ACTION OF GUANIDINE ON VIRUS MULTIPLICATION BY SOME AMINO ACIDS.

Authors:  Z DINTER; S BENGTSSON
Journal:  Virology       Date:  1964-11       Impact factor: 3.616

2.  Early interactions between poliovirus and ERK cells: some observations on the nature and significance of the rejected particles.

Authors:  M L FENWICK; P D COOPER
Journal:  Virology       Date:  1962-10       Impact factor: 3.616

3.  Neurotoxoid interference with two human strains of poliomyelitis in rhesus monkeys.

Authors:  M SANDERS; M G SORET; B A AKIN
Journal:  Ann N Y Acad Sci       Date:  1953-11-30       Impact factor: 5.691

Review 4.  Cell-penetrating inhibitors of calpain.

Authors:  S Mehdi
Journal:  Trends Biochem Sci       Date:  1991-04       Impact factor: 13.807

Review 5.  Poliovirus RNA replication.

Authors:  O C Richards; E Ehrenfeld
Journal:  Curr Top Microbiol Immunol       Date:  1990       Impact factor: 4.291

6.  Viral therapy: prospects for protease inhibitors.

Authors:  B D Korant; T Towatari; L Ivanoff; S Petteway; J Brzin; B Lenarcic; V Turk
Journal:  J Cell Biochem       Date:  1986       Impact factor: 4.429

7.  Isatin-beta-thiosemicarbazone causes premature cessation of vaccinia virus-induced late post-replicative polypeptide synthesis.

Authors:  T H Pennington
Journal:  J Gen Virol       Date:  1977-06       Impact factor: 3.891

8.  Chemical modification potentiates the biological activities of 2-5A and its congeners.

Authors:  J Imai; M I Johnston; P F Torrence
Journal:  J Biol Chem       Date:  1982-11-10       Impact factor: 5.157

9.  Therapeutic activity of enviroxime against rhinovirus infection in volunteers.

Authors:  R J Phillpotts; J Wallace; D A Tyrrell; V B Tagart
Journal:  Antimicrob Agents Chemother       Date:  1983-05       Impact factor: 5.191

10.  Antiviral and antimetabolic activities of neplanocins.

Authors:  E De Clercq
Journal:  Antimicrob Agents Chemother       Date:  1985-07       Impact factor: 5.191

View more
  17 in total

1.  In vitro screening of traditionally used medicinal plants in China against enteroviruses.

Authors:  Jin-Peng Guo; Ji Pang; Xin-Wei Wang; Zhi-Qiang Shen; Min Jin; Jun-Wen Li
Journal:  World J Gastroenterol       Date:  2006-07-07       Impact factor: 5.742

2.  Foot-and-mouth disease virus and poliovirus particles contain proteins of the replication complex.

Authors:  J F Newman; F Brown
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

3.  Simple in vitro translation assay to analyze inhibitors of rhinovirus proteases.

Authors:  B A Heinz; J Tang; J M Labus; F W Chadwell; S W Kaldor; M Hammond
Journal:  Antimicrob Agents Chemother       Date:  1996-01       Impact factor: 5.191

4.  Inhibition of polyprotein processing and RNA replication of human rhinovirus by pyrrolidine dithiocarbamate involves metal ions.

Authors:  B M Krenn; B Holzer; E Gaudernak; A Triendl; F J van Kuppeveld; J Seipelt
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

5.  Efficient virus extinction by combinations of a mutagen and antiviral inhibitors.

Authors:  N Pariente; S Sierra; P R Lowenstein; E Domingo
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

6.  Enhanced intracellular calcium concentration during poliovirus infection.

Authors:  A Irurzun; J Arroyo; A Alvarez; L Carrasco
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

7.  A poliovirus 2A(pro) mutant unable to cleave 3CD shows inefficient viral protein synthesis and transactivation defects.

Authors:  I Ventoso; L Carrasco
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

8.  Cleavage of eukaryotic translation initiation factor 4G by exogenously added hybrid proteins containing poliovirus 2Apro in HeLa cells: effects on gene expression.

Authors:  I Novoa; L Carrasco
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

9.  Poliovirus infection and expression of the poliovirus protein 2B provoke the disassembly of the Golgi complex, the organelle target for the antipoliovirus drug Ro-090179.

Authors:  I V Sandoval; L Carrasco
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

10.  Activation of the translational suppressor 4E-BP1 following infection with encephalomyocarditis virus and poliovirus.

Authors:  A C Gingras; Y Svitkin; G J Belsham; A Pause; N Sonenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.